Law360
10 Global Challenges For Life Sciences Cos. In 2016
January 27, 2016
Life sciences companies face many challenges for 2016, including the demand to develop innovative products at reduced cost. More and more, this means that companies must assess opportunities in major markets across the globe and seek value-maximizing partnerships at all phases of the product life cycle, from development to manufacturing to marketing. The increasingly global and increasingly interconnected nature of the life sciences industry also means that companies must track litigation, policy, regulatory and enforcement developments in the U.S., EU, Asia and other major markets, and must also anticipate the ways in which these developments will impact business opportunities.
Contacts

Capabilities
Suggested News & Insights
Inside Strategic Partnerships: Clinical Trial Considerations and AI/Digital Health InsightsThursday, March 12, 2026Sidley Represents Sensei Biotherapeutics in Acquisition of Faeth TherapeuticsFebruary 18, 2026Law360 Profiles Sidley as a 2025 Compliance Group of the YearFebruary 18, 2026Sidley Represents Arsenal Capital Partners and MaxHealth in Sale of MaxHealth to CenterWellFebruary 17, 2026Sidley Shortlisted for Deal of the Year and Attorney of the Year at D CEO Mergers & Acquisition Awards 2026February 17, 2026Life Sciences College 2026Thursday, February 12, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

